Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Lakewood-Amedex Biotherapeutics Inc.

NASDAQ: LABT · Life Sciences · 3 alerts · CIK 2079272

Share price
$0.2194Close, Nov 16
Market cap
$520K
Shares outstanding
2.37MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Lakewood-Amedex Biotherapeutics Inc. filings on SEC EDGAR ↗

4:41 PM ET 8-K
Nasdaq/NYSE Compliance Notice

Lakewood-Amedex Biotherapeutics Nasdaq/NYSE Compliance Notice

Lakewood-Amedex Biotherapeutics received a delisting notice from Nasdaq on November 10, 2026, because its common stock failed to maintain the $1.00 minimum bid price for 30 consecutive business days. Due to a prior reverse stock split within the last year, the company is ineligible for a standard compliance period and faces immediate suspension unless it successfully appeals to a Nasdaq Hearings Panel. The company intends to request a hearing to stay the delisting and present a plan to regain compliance.

Counterparty
The Nasdaq Stock Market LLC

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.